CASBF
Price:
$4.44
Market Cap:
$12.08B
CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides. It also develops DTcP vaccine for infants and DTcP Booster vaccine, which are in Phase I clinical trial for addressing the weaker protection preventing pertussis after primary vaccination. Further, the company develops Tdcp Adolescent and Adult vaccine for treating pertussis; PBPV, a serotype-independent protein-based pneumococcal vaccine that is in Phase I clinical trial;...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2020-01-02
Stock Exchange
OTC
Ticker
CASBF
According to CanSino Biologics Inc.’s latest financial reports and current stock price. The company's current ROE is -2.87%. This represents a change of 310.08% compared to the average of -0.70% of the last 4 quarters.
The mean historical ROE of CanSino Biologics Inc. over the last ten years is -11.55%. The current -2.87% ROE has changed -75.15% with respect to the historical average. Over the past ten years (40 quarters), CASBF's ROE was at its highest in in the June 2021 quarter at 13.56%. The ROE was at its lowest in in the June 2023 quarter at -11.87%.
Average
-11.55%
Median
-10.66%
Minimum
-28.11%
Maximum
23.94%
Discovering the peaks and valleys of CanSino Biologics Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 159.41%
Maximum Annual ROE = 23.94%
Minimum Annual Increase = -466.49%
Minimum Annual ROE = -28.11%
| Year | ROE | Change |
|---|---|---|
| 2024 | -7.72% | -72.55% |
| 2023 | -28.11% | 108.59% |
| 2022 | -13.48% | -156.28% |
| 2021 | 23.94% | -466.49% |
| 2020 | -6.53% | -38.71% |
| 2019 | -10.66% | -61.27% |
| 2018 | -27.53% | 159.41% |
| 2017 | -10.61% | -54.34% |
The current ROE of CanSino Biologics Inc. (CASBF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-16.43%
5-year avg
-6.38%
10-year avg
-11.55%
CanSino Biologics Inc.’s ROE is less than Tsumura & Co. (8.71%), less than Hisamitsu Pharmaceutical Co., Inc. (7.23%), greater than Sihuan Pharmaceutical Holdings Group Ltd. (-1.84%), greater than Curaleaf Holdings, Inc. (-27.88%), less than Dermapharm Holding SE (17.61%), less than Almirall, S.A. (1.44%), less than Fagron N.V. (17.09%), less than China Medical System Holdings Limited (9.90%), greater than Aspen Pharmacare Holdings Limited (-1.27%), less than Nippon Shinyaku Co., Ltd. (12.46%),
| Company | ROE | Market cap |
|---|---|---|
| 8.71% | $1.72B | |
| 7.23% | $2.11B | |
| -1.84% | $1.92B | |
| -27.88% | $2.01B | |
| 17.61% | $2.13B | |
| 1.44% | $2.87B | |
| 17.09% | $1.72B | |
| 9.90% | $3.26B | |
| -1.27% | $2.46B | |
| 12.46% | $2.06B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CanSino Biologics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CanSino Biologics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is CanSino Biologics Inc.'s ROE?
How is the ROE calculated for CanSino Biologics Inc. (CASBF)?
What is the highest ROE for CanSino Biologics Inc. (CASBF)?
What is the 3-year average ROE for CanSino Biologics Inc. (CASBF)?
What is the 5-year average ROE for CanSino Biologics Inc. (CASBF)?
How does the current ROE for CanSino Biologics Inc. (CASBF) compare to its historical average?